Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIIIW) Common Equity (2019 - 2025)

P3 Health Partners' Common Equity history spans 7 years, with the latest figure at -$155.2 million for Q4 2025.

  • For Q4 2025, Common Equity fell 304.38% year-over-year to -$155.2 million; the TTM value through Dec 2025 reached -$155.2 million, down 304.38%, while the annual FY2025 figure was -$155.2 million, 304.38% down from the prior year.
  • Common Equity reached -$155.2 million in Q4 2025 per PIIIW's latest filing, down from -$18.7 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $263.0 million in Q1 2022 to a low of -$272.9 million in Q4 2021.
  • Average Common Equity over 5 years is $13.2 million, with a median of $53.9 million recorded in 2025.
  • Peak YoY movement for Common Equity: soared 5559.81% in 2024, then tumbled 304.38% in 2025.
  • A 5-year view of Common Equity shows it stood at -$272.9 million in 2021, then skyrocketed by 102.14% to $5.9 million in 2022, then soared by 2327.91% to $142.1 million in 2023, then plummeted by 46.57% to $75.9 million in 2024, then tumbled by 304.38% to -$155.2 million in 2025.
  • Per Business Quant, the three most recent readings for PIIIW's Common Equity are -$155.2 million (Q4 2025), -$18.7 million (Q3 2025), and $44.5 million (Q2 2025).